Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02. (Q46069967)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

phase III clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

toxic encephalopathy

1 reference

based on heuristic

inferred from title

Katsumasa Kuroi

6

object named as

Katsumasa Kuroi

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

author name string

Kojiro Shimozuma

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

Yasuo Ohashi

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

Ayano Takeuchi

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

Toshihiko Aranishi

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

Satoshi Morita

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

Shozo Ohsumi

7

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

Haruhiko Makino

8

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

Hirohumi Mukai

9

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

Noriyuki Katsumata

10

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

Yoshihide Sunada

11

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

Toru Watanabe

12

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

Frederick H Hausheer

13

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

publication date

28 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

Supportive Care in Cancer

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

17

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

12

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

1483-1491

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

https://scigraph.springernature.com/pub.10.1007/s00520-009-0613-7

0 references

Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings?

1 reference

https://api.crossref.org/works/10.1007%2FS00520-009-0613-7

21 January 2018

Chemotherapy-induced neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Grading of chemotherapy-induced peripheral neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Techniques for the neurological examination of taxane-induced neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comprehensive criteria for assessing therapy-induced toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy-induced peripheral neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cross-cultural validation of an international questionnaire, the General Measure of the Functional Assessment of Cancer Therapy scale (FACT-G), for Japanese

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurotoxicity of taxanes: symptoms and quality of life assessment

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of quality of life questionnaire in Japan: quality of life assessment of cancer patients receiving chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Measurement of Observer Agreement for Categorical Data

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation and reduction of FACT/GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: a gynecologic oncology group study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing health-related quality of life in palliative care: comparing patient and physician assessments.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient-reported outcomes assessment in cancer trials: taking stock, moving forward

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Symptom, symptom experiences, and symptom distress encountered by women with breast cancer undergoing current treatment modalities

1 reference

https://pubmed.ncbi.nlm.nih.gov/19330359

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00520-009-0613-7

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19330359

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46069967&oldid=1756370313"